(Q28306851)

26 November 2024

1 reference

1 reference

Ryo Yamasaki

1 reference

Europe PubMed Central

PubMed publication ID

21387370

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21387370

26 November 2024

Tetsuya Hashimoto

1 reference

Europe PubMed Central

PubMed publication ID

21387370

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21387370

26 November 2024

author name string

Eri Himeno

0 references

Yasumasa Ohyagi

0 references

Linqing Ma

0 references

Norimichi Nakamura

0 references

Katsue Miyoshi

0 references

Nobutaka Sakae

0 references

Kyoko Motomura

0 references

Naoko Soejima

0 references

Takeshi Tabira

0 references

Jun-ichi Kira

0 references

Frank M. LaFerla

1 reference

Europe PubMed Central

PubMed publication ID

21387370

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21387370

full work available at URL

26 November 2024

language of work or name

English

0 references

publication date

February 2011

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.22319

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.22319

26 November 2024

1 reference

Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease

26 November 2024

0 references

0 references

0 references

248-56

0 references

cites work

1 reference

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

Drug development for Alzheimer's disease: where are we now and where are we headed?

21 January 2018

1 reference

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease

21 January 2018

1 reference

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

21 January 2018

1 reference

Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice

21 January 2018

1 reference

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease

21 January 2018

1 reference

Apomorphine for the acute treatment of "off" episodes in Parkinson's disease

21 January 2018

1 reference

Central Mechanisms Regulating Penile Erection in Conscious Rats: The Dopaminergic Systems Related to the Proerectile Effect of Apomorphine

21 January 2018

1 reference

Apomorphine protects against MPTP-induced neurotoxicity in mice

21 January 2018

1 reference

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

21 January 2018

1 reference

Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

Protection by apomorphine in two independent models of acute inhibition of oxidative metabolism in rodents

21 January 2018

1 reference

Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway

21 January 2018

1 reference

Therapeutic potential of oxidant mechanisms in Alzheimer's disease

21 January 2018

1 reference

New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE

21 January 2018

1 reference

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

21 January 2018

1 reference

Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles

21 January 2018

1 reference

Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice

21 January 2018

1 reference

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

21 January 2018

1 reference

Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease

21 January 2018

1 reference

Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid

21 January 2018

1 reference

Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors

21 January 2018

1 reference

Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging

21 January 2018

1 reference

Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2.

21 January 2018

1 reference

Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors

21 January 2018

1 reference

Neuroprotection in Parkinson models varies with toxin administration protocol

21 January 2018

1 reference

gamma-Secretase dependent production of intracellular domains is reduced in adult compared to embryonic rat brain membranes

21 January 2018

1 reference

Relationship between beta-amyloid degradation and the 26S proteasome in neural cells

21 January 2018

1 reference

beta-Amyloid degradation and Alzheimer's disease

21 January 2018

1 reference

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

21 January 2018

1 reference

Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles

21 January 2018

1 reference

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

21 January 2018

1 reference

Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells

21 January 2018

1 reference

Intracellular amyloid beta-protein and its associated molecules in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

21 January 2018

1 reference

Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology.

21 January 2018

1 reference

Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology

21 January 2018

1 reference

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

21 January 2018

1 reference

A dynamic relationship between intracellular and extracellular pools of Abeta

21 January 2018

1 reference

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

The ubiquitin-proteasome system in Alzheimer's disease

21 January 2018

1 reference

Abeta inhibits the proteasome and enhances amyloid and tau accumulation

21 January 2018

1 reference

Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways

21 January 2018

1 reference

Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C.

21 January 2018

1 reference

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

21 January 2018

1 reference

Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease

26 November 2024

1 reference

Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein

26 November 2024

1 reference

The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.

26 November 2024

1 reference

Dopamine receptor stimulation decreases cytosolic gamma protein kinase C immunoreactivity in rat hippocampal slices: evidence for increased Ca(2+)-dependent proteolysis

26 November 2024

1 reference